The behavioral phenotype of pituitary adenylate-cyclase activating polypeptide-deficient mice in anxiety and depression tests is accompanied by blunted c-Fos expression in the bed nucleus of the stria terminalis, central projecting Edinger-Westphal nucleus, ventral lateral septum, and dorsal raphe nucleus

Neuroscience

Volumn 202, Issue , 2012, Pages 283-299

  Gaszner, B ^a   Kormos, V ^a,b   Kozicz, T ^c   Hashimoto, H ^d,e   Reglodi, D ^a   Helyes, Z ^b  

^a UNIVERSITY OF PÉCS   (Hungary)

^b UNIVERSITY OF PÉCS   (Hungary)

^c RADBOUD UNIVERSITY   (Netherlands)

^d OSAKA UNIVERSITY   (Japan)

^e OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Amygdala; Bed nucleus of stria terminalis; Dorsal raphe nucleus; Edinger Westphal nucleus; Hypothalmic paraventricular nucleus; Stress

Indexed keywords

HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; PROTEIN C FOS;

ANIMAL EXPERIMENT; ANXIETY; ARTICLE; BASOLATERAL AMYGDALA; CELLULAR STRESS RESPONSE; CENTRAL NUCLEUS (AMYGDALA); CONTROLLED STUDY; DEPRESSION; DORSAL RAPHE NUCLEUS; EDINGER WESTPHAL NUCLEUS; ENZYME ACTIVATION; EXPERIMENTAL TEST; FORCED SWIMMING TEST; IMMEDIATE EARLY GENE; IMMUNOCYTOCHEMISTRY; LOCOMOTION; MALE; MARBLE BURYING TEST; MEDIAL AMYGDALA; MENTAL STRESS; MOUSE; NONHUMAN; OPEN FIELD TEST; PARAVENTRICULAR THALAMIC NUCLEUS; PRIORITY JOURNAL; STRIA TERMINALIS; THALAMUS DORSOMEDIAL NUCLEUS; THALAMUS VENTRAL NUCLEUS; WILD TYPE;

ANIMALS; ANXIETY; BEHAVIOR, ANIMAL; DEPRESSION; GANGLIA, PARASYMPATHETIC; GENE EXPRESSION; GENES, FOS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOHISTOCHEMISTRY; MALE; MICE; MICE, KNOCKOUT; MOTOR ACTIVITY; OCULOMOTOR NERVE; PARAVENTRICULAR HYPOTHALAMIC NUCLEUS; PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE; PROTO-ONCOGENE PROTEINS C-FOS; RAPHE NUCLEI; SEPTAL NUCLEI; SEPTUM OF BRAIN; STRESS, PSYCHOLOGICAL; SWIMMING;

EID: 84856231983     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2011.11.046     Document Type: Article

References (79)

1. Agarwal A., Halvorson L.M., Legradi G. Pituitary adenylate cyclase-activating polypeptide (PACAP) mimics neuroendocrine and behavioral manifestations of stress: evidence for PKA-mediated expression of the corticotropin-releasing hormone (CRH) gene. Brain Res Mol Brain Res 2005, 138:45-57.
2. Badowska-Szalewska E., Klejbor I., Cecot T., Spodnik J.H., Moryś J. Changes in NGF/c-Fos double staining in the structures of the limbic system in juvenile and aged rats exposed to forced swim test. Acta Neurobiol Exp 2009, 69:448-458.
3. Bittencourt J.C., Vaughan J., Arias C., Rissman R.A., Vale W.W., Sawchenko P.E. Urocortin expression in rat brain: evidence against a pervasive relationship of urocortin-containing projections with targets bearing type 2 CRF receptors. J Comp Neurol 1999, 415:285-312.
4. Blackwood D.H., Fordyce A., Walker M.T., St Clair D.M., Porteous D.J., Muir W.J. Schizophrenia and affective disorders-cosegregation with a translocation at chromosome 1q42 that directly disrupts brain-expressed genes: clinical and P300 findings in a family. Am J Hum Genet 2001, 69:428-433.
5. Bourin M., Hascoët M. The mouse light/dark box test. Eur J Pharmacol 2003, 463:55-65.
6. Bouwknecht J.A., Spiga F., Staub D.R., Hale M.W., Shekhar A., Lowry C.A. Differential effects of exposure to low-light or high-light open-field on anxiety-related behaviors: relationship to c-Fos expression in serotonergic and non-serotonergic neurons in the dorsal raphe nucleus. Brain Res Bull 2007, 72:32-43.
7. Cryan J.F., Mombereau C. In search of a depressed mouse: utility of models for studying depression-related behavior in genetically modified mice. Mol Psychiatry 2004, 9:326-357.
8. Cullinan W.E., Herman J.P., Battaglia D.F., Akil H., Watson S.J. Pattern and time course of immediate early gene expression in rat brain following acute stress. Neuroscience 1995, 64:477-505.
9. Das M., Vihlen C.S., Legradi G. Hypothalamic and brainstem sources of pituitary adenylate cyclase-activating polypeptide nerve fibers innervating the hypothalamic paraventricular nucleus in the rat. J Comp Neurol 2007, 500:761-776.
10. de Kloet E.R. About stress hormones and resilience to psychopathology. J Neuroendocrinol 2008, 20:885-892.
11. Dong H.W., Petrovich G.D., Watts A.G., Swanson L.W. Basic organization of projections from the oval and fusiform nuclei of the bed nuclei of the stria terminalis in adult rat brain. J Comp Neurol 2001, 436:430-455.
12. Duncan G.E., Johnson K.B., Breese G.R. Topographic patterns of brain activity in response to swim stress: assessment by 2-deoxyglucose uptake and expression of Fos-like immunoreactivity. J Neurosci 1993, 13:3932-3943.
13. Gaszner B., Csernus V., Kozicz T. Urocortinergic neurons respond in a differentiated manner to various acute stressors in the Edinger-Westphal nucleus in the rat. J Comp Neurol 2004, 480:170-179.
14. Gaszner B., Jensen K.O., Farkas J., Reglodi D., Csernus V., Roubos E.W., Kozicz T. Effects of maternal separation on dynamics of urocortin 1 and brain-derived neurotrophic factor in the rat non-preganglionic Edinger-Westphal nucleus. Int J Dev Neurosci 2009, 27:439-451.
15. Gaszner B., Korosi A., Palkovits M., Roubos E.W., Kozicz T. Neuropeptide Y activates urocortin 1 neurons in the nonpreganglionic Edinger-Westphal nucleus. J Comp Neurol 2007, 500:708-719.
16. Gardner K.L., Thrivikraman K.V., Lightman S.L., Plotsky P.M., Lowry C.A. Early life experience alters behavior during social defeat: focus on serotonergic systems. Neuroscience 2005, 136:181-191.
17. Geyer M.A., Markou A. Animal models of psychiatric disorders. Psychopharmacology: the fourth generation of progress 1995, 787-798. Raven, New York. F.E. Bloom, D.J. Kupfer (Eds.).
18. Ghasemi M., Montaser-Kouhsari L., Shafaroodi H., Nezami B.G., Ebrahimi F., Dehpour A.R. NMDA receptor/nitrergic system blockage augments antidepressant-like effects of paroxetine in the mouse forced swimming test. Psychopharmacology (Berl) 2009, 206:325-333.
19. Girard B.A., Lelievre V., Braas K.M., Razinia T., Vizzard M.A., Ioffe Y., El Meskini R., Ronnett G.V., Waschek J.A., May V. Noncompensation in peptide/receptor gene expression and distinct behavioral phenotypes in VIP- and PACAP-deficient mice. J Neurochem 2006, 99:499-513.
20. Graeff F.G., Zangrossi H. The dual role of serotonin in defense and the mode of action of antidepressants on generalized anxiety and panic disorders. Cent Nerv Syst Agents Med Chem 2010, 10:207-217.
21. Grinevich V., Fournier A., Pelletier G. Effects of pituitary adenylate cyclase-activating polypeptide (PACAP) on corticotropin-releasing hormone (CRH) gene expression in the rat hypothalamic paraventricular nucleus. Brain Res 1997, 773:190-196.
22. Hammack S.E., Cheung J., Rhodes K.M., Schutz K.C., Falls W.A., Braas K.M., May V. Chronic stress increases pituitary adenylate cyclase-activating peptide (PACAP) and brain-derived neurotrophic factor (BDNF) mRNA expression in the bed nucleus of the stria terminalis (BNST): roles for PACAP in anxiety-like behavior. Psychoneuroendocrinology 2009, 34:833-843.
23. Hammack SE, Cooper MA, Lezak KR (in press) Overlapping neurobiology of learned helplessness and conditioned defeat: implications for PTSD and mood disorders. Neuropharmacology, doi:10.1016/j.neuropharm.2011.02.024.
24. Hammack S.E., Roman C.W., Lezak K.R., Kocho-Shellenberg M., Grimmig B., Falls W.A., Braas K., May V. Roles for pituitary adenylate cyclase-activating peptide (PACAP) expression and signaling in the bed nucleus of the stria terminalis (BNST) in mediating the behavioral consequences of chronic stress. J Mol Neurosci 2010, 42:327-340.
25. Hannibal J. Pituitary adenylate cyclase-activating peptide in the rat central nervous system: an immunohistochemical and in situ hybridization study. J Comp Neurol 2002, 453:389-417.
26. Hashimoto H., Hashimoto R., Shintani N., Tanaka K., Yamamoto A., Hatanaka M., Guo X., Morita Y., Tanida M., Nagai K., Takeda M., Baba A. Depression-like behavior in the forced swimming test in PACAP-deficient mice: amelioration by the atypical antipsychotic risperidone. J Neurochem 2009, 110:595-602.
27. Hashimoto H., Shintani H., Baba A. New insights into the central PACAPergic system from the phenotypes of PACAP- and PACAP receptor-knockout mice. Ann N Y Acad Sci 2006, 1070:75-89.
28. Hashimoto H., Shintani N., Tanaka K., Mori W., Hirose M., Matsuda T., Sakaue M., Miyazaki J., Niwa H., Tashiro F., Yamamoto K., Koga K., Tomimoto S., Kunugi A., Suetake S., Baba A. Altered psychomotor behaviors in mice lacking pituitary adenylate cyclase-activating polypeptide (PACAP). Proc Natl Acad Sci U S A 2001, 98:13355-13360.
29. Hashimoto H., Shintani N., Tanida M., Hayata A., Hashimoto R., Baba A. PACAP is implicated in the stress axes. Curr Pharm Des 2011, 17:985-989.
30. Hashimoto R., Hashimoto H., Shintani N., Ohi K., Hori H., Saitoh O., Kosuga A., Tatsumi M., Iwata N., Ozaki N., Kamijima K., Baba A., Takeda M., Kunugi H. Possible association between the pituitary adenylate cyclase-activating polypeptide (PACAP) gene and major depressive disorder. Neurosci Lett 2010, 468:300-302.
31. Hattori T., Baba K., Matsuzaki S., Honda A., Miyoshi K., Inoue K., Taniguchi M., Hashimoto H., Shintani N., Baba A., Shimizu S., Yukioka F., Kumamoto N., Yamaguchi A., Tohyama M., Katayama T. A novel DISC1-interacting partner DISC1-Binding zinc-finger protein: implication in the modulation of DISC1-dependent neurite outgrowth. Mol Psychiatry 2007, 12:398-407.
32. Heinricher M.M., Tavares I., Leith J.L., Lumb B.M. Descending control of nociception: specificity, recruitment and plasticity. Brain Res Rev 2009, 60:214-225.
33. Herman J.P., Figueiredo H., Mueller N.K., Ulrich-Lai Y., Ostrander M.M., Choi D.C., Cullinan W.E. Central mechanisms of stress integration: hierarchical circuitry controlling hypothalamo-pituitary-adrenocortical responsiveness. Front Neuroendocrinol 2003, 24:151-180.
34. Hornung J.P. The human raphe nuclei and the serotonergic system. J Chem Neuroanat 2003, 26:331-343.
35. Kageyama K., Suda T. Regulatory mechanisms underlying corticotropin-releasing factor gene expression in the hypothalamus. Endocr J 2009, 56:335-344.
36. Kim S.H., Han J.E., Hwang S., Oh D.H. The expression of corticotropin-releasing factor in the central nucleus of the amygdala, induced by colorectal distension, is attenuated by general anesthesia. J Korean Med Sci 2010, 25:1646-1651.
37. Kovács K.J. c-Fos as a transcription factor: a stressful (re)view from a functional map. Neurochem Int 1998, 33:287-297.
38. Kovács K.J. Measurement of immediate-early gene activation- c-fos and beyond. J Neuroendocrinol 2008, 20:665-672.
39. Köves K., Görcs T.J., Kausz M., Arimura A. Present status of knowledge about the distribution and colocalization of PACAP in the forebrain. Acta Biol Hung 1994, 45:297-321.
40. Kozicz T. On the role of urocortin 1 in the non-preganglionic Edinger-Westphal nucleus in stress adaptation. Gen Comp Endocrinol 2007, 153:235-240.
41. Kozicz T. The missing link; the significance of urocortin 1/urocortin 2 in the modulation of the dorsal raphe serotoninergic system. Mol Psychiatry 2010, 15:340-341.
42. Kozicz T., Bittencourt J.C., May P.J., Reiner A., Gamlin P.D., Palkovits M., Horn A.K., Toledo C.A., Ryabinin A.E. The Edinger-Westphal nucleus: a historical, structural and functional perspective on a dichotomous terminology. J Comp Neurol 2011, 519:1413-1434.
43. Kozicz T., Min L., Arimura A. The activation of urocortin immunoreactive neurons in the Edinger-Westphal nucleus following acute pain stress in rats. Stress 2001, 4:85-90.
44. Kozicz T., Tilburg-Ouwens D., Faludi G., Palkovits M., Roubos E. Gender-related urocortin 1 and brain-derived neurotrophic factor expression in the adult human midbrain of suicide victims with major depression. Neuroscience 2008, 152:1015-1023.
45. Kozicz T., Vigh S., Arimura A. Axon instruments terminals containing PACAP- and VIP-immunoreactivity form synapses with CRF-immunoreactive neurons in the dorsolateral division of the bed nucleus of the stria terminalis in the rat. Brain Res 1997, 767:109-119.
46. Liposits Z., Phelix C., Paull W.K. Synaptic interaction of serotonergic axons and corticotropin releasing factor (CRF) synthesizing neurons in the hypothalamic paraventricular nucleus of the rat. A light and electron microscopic immunocytochemical study. Histochemistry 1987, 86:541-549.
47. Liu X., Tang X., Sanford L.D. Stressor controllability and Fos expression in stress regulatory regions in mice. Physiol Behav 2009, 97:321-326.
48. Lowry C.A., Hale M.W., Evans A.K., Heerkens J., Staub D.R., Gasser P.J., Shekhar A. Serotonergic systems, anxiety, and affective disorder: focus on the dorsomedial part of the dorsal raphe nucleus. Ann N Y Acad Sci 2008, 1148:86-94.
49. McEvoy P.M., Grove R., Slade T. Epidemiology of anxiety disorders in the Australian general population: findings of the 2007 Australian National Survey of Mental Health and Wellbeing. Aust N Z J Psychiatry 2011, 45:957-967.
50. McEwen B.S., Gianaros P.J. Central role of the brain in stress and adaptation: links to socioeconomic status, health, and disease. Ann N Y Acad Sci 2010, 1186:190-222.
51. Millar J.K., Wilson-Annan J.C., Anderson S., Christie S., Taylor M.S., Semple C.A., Devon R.S., St Clair D.M., Muir W.J., Blackwood D.H., Porteous D.J. Disruption of two novel genes by a translocation co-segregating with schizophrenia. Hum Mol Genet 2000, 9:1415-1423.
52. Neufeld-Cohen A., Evans A.K., Getselter D., Spyroglou A., Hill A., Gil S., Tsoory M., Beuschlein F., Lowry C.A., Vale W., Chen A. Urocortin-1 and -2 double-deficient mice show robust anxiolytic phenotype and modified serotonergic activity in anxiety circuits. Mol Psychiatry 2010, 15:426-441.
53. Nijsen M.J., Croiset G., Diamant M., De Wied D., Wiegant V.M. CRH signalling in the bed nucleus of the stria terminalis is involved in stress-induced cardiac vagal activation in conscious rats. Neuropsychopharmacology 2001, 24:1-10.
54. Njung'e K., Handley S.L. Evaluation of marble-burying behavior as a model of anxiety. Pharmacol Biochem Behav 1991, 38:63-67.
55. Norrholm S.D., Das M., Légrádi G. Behavioral effects of local microinfusion of pituitary adenylate cyclase activating polypeptide (PACAP) into the paraventricular nucleus of the hypothalamus (PVN). Regul Pept 2005, 128:33-41.
56. Ons S., Rotllant D., Marín-Blasco I.J., Armario A. Immediate-early gene response to repeated immobilization: Fos protein and arc mRNA levels appear to be less sensitive than c-fos mRNA to adaptation. Eur J Neurosci 2010, 31:2043-2052.
57. Otto C., Kovalchuk Y., Wolfer D.P., Gass P., Martin M., Zuschratter W., Gröne H.J., Kellendonk C., Tronche F., Maldonado R., Lipp H.P., Konnerth A., Schütz G. Impairment of mossy fiber long-term potentiation and associative learning in pituitary adenylate cyclase activating polypeptide type I receptor-deficient mice. J Neurosci 2001, 21:5520-5527.
58. Paxinos G., Franklin K. The mouse brain in stereotaxic coordinatres 2003, Elsevier Academic, San Diego. 3rd ed.
59. Pinhasov A., Nesher E., Gross M., Turgeman G., Kreinin A., Yadid G. The role of the PACAP signaling system in depression. Curr Pharm Des 2011, 17:990-1001.
60. Porsolt R.D., Bertin A., Jalfre M. Behavioral despair in mice: a primary screening test for antidepressants. Arch Int Pharmacodyn Ther 1977, 229:327-336.
61. Regev L., Neufeld-Cohen A., Tsoory M., Kuperman Y., Getselter D., Gil S., Chen A. Prolonged and site-specific over-expression of corticotropin-releasing factor reveals differential roles for extended amygdala nuclei in emotional regulation. Mol Psychiatry 2011, 16:714-728.
62. Ressler K.J., Mercer K.B., Bradley B., Jovanovic T., Mahan A., Kerley K., Norrholm S.D., Kilaru V., Smith A.K., Myers A.J., Ramirez M., Engel A., Hammack S.E., Toufexis D., Braas K.M., Binder E.B., May V. Post-traumatic stress disorder is associated with PACAP and the PAC1 receptor. Nature 2011, 470:492-497.
63. Rouwette T., Klemann K., Gaszner B., Scheffer G.J., Roubos E.W., Scheenen W.J., Vissers K., Kozicz T. Differential responses of corticotropin-releasing factor and urocortin 1 to acute pain stress in the rat brain. Neuroscience 2011, 183:15-24.
64. Ryabinin A.E., Wang Y.M., Finn D.A. Different levels of Fos immunoreactivity after repeated handling and injection stress in two inbred strains of mice. Pharmacol Biochem Behav 1999, 63:143-151.
65. Sándor K., Kormos V., Botz B., Imreh A., Bölcskei K., Gaszner B., Markovics A., Szolcsányi J., Shintani N., Hashimoto H., Baba A., Reglodi D., Helyes Z. Impaired nocifensive behaviours and mechanical hyperalgesia, but enhanced thermal allodynia in pituitary adenylate cyclase-activating polypeptide deficient mice. Neuropeptides 2010, 44:363-371.
66. Savitz J., Lucki I., Drevets W.C. 5-HT(1A) receptor function in major depressive disorder. Prog Neurobiol 2009, 88:17-31.
67. Sawchenko P.E., Swanson L.W., Steinbusch H.W., Verhofstad A.A. The distribution and cells of origin of serotonergic inputs to the paraventricular and supraoptic nuclei of the rat. Brain Res 1983, 277:355-360.
68. Schmidt M.V., Sterlemann V., Wagner K., Niederleitner B., Ganea K., Liebl C., Deussing J.M., Berger S., Schütz G., Holsboer F., Müller M.B. Postnatal glucocorticoid excess due to pituitary glucocorticoid receptor deficiency: differential short- and long-term consequences. Endocrinology 2009, 150:2709-2716.
69. Shapiro S.S., Wilk M.B. An analysis of variance test for normality. Biometrika 1965, 52:591-599.
70. Shintani N., Mori W., Hashimoto H., Imai M., Tanaka K., Tomimoto S., Hirose M., Kawaguchi C., Baba A. Defects in reproductive functions in PACAP-deficient female mice. Regul Pept 2002, 109:45-48.
71. Singewald G.M., Rjabokon A., Singewald N., Ebner K. The modulatory role of the lateral septum on neuroendocrine and behavioral stress responses. Neuropsychopharmacology 2011, 36:793-804.
72. Snedecor G.W., Cochran W.G. Statistical methods 1989, Iowa State University Press, Ames. 8th ed.
73. Stone E.A., Lehmann M.L., Lin Y., Quartermain D. Reduced evoked fos expression in activity-related brain regions in animal models of behavioral depression. Prog Neuropsychopharmacol Biol Psychiatry 2007, 31:1196-1207.
74. Stone E.A., Lin Y., Sarfraz Y., Quartermain D. Antidepressant-like action of intracerebral 6-fluoronorepinephrine, a selective full α-adrenoceptor agonist. Int J Neuropsychopharmacol 2011, 14:319-331.
75. Stroth N., Eiden L.E. Stress hormone synthesis in mouse hypothalamus and adrenal gland triggered by restraint is dependent on pituitary adenylate cyclase-activating polypeptide signaling. Neuroscience 2010, 165:1025-1030.
76. Tsukiyama N., Saida Y., Kakuda M., Shintani N., Hayata A., Morita Y., Tanida M., Tajiri M., Hazama K., Ogata K., Hashimoto H., Baba A. PACAP centrally mediates emotional stress-induced corticosterone responses in mice. Stress 2011, 14:368-375.
77. Valentino R.J., Lucki I., Van Bockstaele E. Corticotropin-releasing factor in the dorsal raphe nucleus: linking stress coping and addiction. Brain Res 2010, 1314:29-37.
78. Vaudry D., Falluel-Morel A., Bourgault S., Basille M., Burel D., Wurtz O., Fournier A., Chow B.K., Hashimoto H., Galas L., Vaudry H. Pituitary adenylate cyclase-activating polypeptide and its receptors: 20 years after the discovery. Pharmacol Rev 2009, 61:283-357.
79. Westenbroek C., Ter Horst G.J., Roos M.H., Kuipers S.D., Trentani A., den Boer J.A. Gender-specific effects of social housing in rats after chronic mild stress exposure. Prog Neuropsychopharmacol Biol Psychiatry 2003, 27:21-30.